文献速递自身免疫性与大疱性皮肤病银屑病与炎症性皮肤病

系统性红斑狼疮及其他自身免疫性皮肤病患者中的疲劳

Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
PubMed 文献 · Br J Dermatol · 2018-11-22

这项回顾性研究比较了对照组与系统性红斑狼疮、皮肤型红斑狼疮、无肌病性皮肌炎和自身免疫性大疱病患者疲劳情况,发现各疾病组的疲劳均重于对照组,其中系统性红斑狼疮最重,且疲劳对生活质量有负面影响,应被临床关注并在未来临床试验中测量。

要点

  • 各自身免疫性皮肤病组的疲劳均重于对照组,系统性红斑狼疮最重。
  • 皮肤型红斑狼疮、无肌病性皮肌炎和自身免疫性大疱病组间疲劳无差异。
  • 系统性红斑狼疮的临床显著疲劳比例高于皮肤型红斑狼疮。

核心结论

  • 皮肤局限性自身免疫病患者比对照组经历更多疲劳,疲劳是影响生活质量的重要症状,应被临床医生关注并在未来临床试验中测量。

研究设计与样本

  • 回顾性研究,比较对照组(n=84)与来自前瞻性纵向数据库的系统性红斑狼疮(n=165)、皮肤型红斑狼疮(n=226)、无肌病性皮肌炎(n=136)和自身免疫性大疱病(n=79)患者的疲劳。

主要发现

  • SF-36活力评分中位数(IQR):系统性红斑狼疮35(20-55),皮肤型红斑狼疮50(30-70),无肌病性皮肌炎50(30-65),自身免疫性大疱病55(35-70),对照组73(65-85);各疾病组 vs 对照组 P<0.05。
  • 系统性红斑狼疮组疲劳重于其他各组(系统性红斑狼疮 vs 各组 P<0.05),皮肤型红斑狼疮、无肌病性皮肌炎和自身免疫性大疱病组间无差异(均 P>0.05)。
  • 临床显著疲劳(评分≤35)比例:系统性红斑狼疮44.2%,皮肤型红斑狼疮25.2%,无肌病性皮肌炎31.6%,自身免疫性大疱病24.1%,对照组2%;各疾病组 vs 对照组 P<0.01。
  • 系统性红斑狼疮组临床显著疲劳多于皮肤型红斑狼疮组(P<0.01);系统性红斑狼疮与无肌病性皮肌炎(P=0.17)或自身免疫性大疱病(P=0.055)间无差异。

临床怎么用

  • 作者认为疲劳是影响皮肤局限性自身免疫病患者生活质量的重要症状,应被临床医生关注并在未来临床试验中测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fatigue is a well-established symptom in systemic lupus erythematosus (SLE), but has not been well characterized in other skin-limited autoimmune diseases such as cutaneous lupus erythematosus (CLE), amyopathic dermatomyositis (ADM) or autoimmune blistering diseases (AIBD). OBJECTIVES: In this retrospective study, we compared fatigue in controls (n = 84) with that in patients enrolled in prospective longitudinal databases with SLE (n = 165), CLE (n = 226), ADM (n = 136) and AIBD (n = 79). METHODS: We used the 36-Item Short Form Survey (SF-36) vitality scale to analyse median scores and the percentages of patients with clinically significant fatigue (defined as a score ≤ 35) between experimental groups and controls. RESULTS: Median and interquartile range (IQR) vitality scores demonstrated greater fatigue in the experimental groups (SLE 35, IQR 20-55; CLE 50, IQR 30-70; ADM 50, IQR 30-65; AIBD 55, IQR 35-70) than in controls (73, IQR 65-85) (P < 0·05 for each experimental group vs. control). The SLE group had worse fatigue than all of the other groups (P < 0·05 SLE vs. each group), but there was no difference between the CLE, ADM or AIBD groups (all P > 0·05). In addition, the experimental groups had more clinically significant fatigue (score ≤ 35) (SLE 44·2%, CLE 25·2%, ADM 31·6%, AIBD 24·1%) than controls (2%) (P < 0·01 for each experimental group vs. control). The SLE group had more clinically significant fatigue than the CLE group (P < 0·01); however, there was no difference in clinically significant fatigue between SLE and either ADM (P = 0·17) or AIBD (P = 0·055). CONCLUSIONS: These findings demonstrate that patients with skin-limited autoimmune disease experience more fatigue than controls. Fatigue is an important symptom that negatively affects quality of life for patients. It should be addressed by clinicians and measured in future clinical trials.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Tarazi M, Gaffney RG, Pearson D, et al. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases. Br J Dermatol. 2018. PMID: 30269332. doi:10.1111/bjd.17257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。